William J. Gradishar, MD, on Triple-Negative Breast Cancer: NCCN Guidelines Update

March 19, 2021 By The ASCO Post Staff

William J. Gradishar, MD, of Robert H. Lurie Comprehensive Cancer Center of Northwestern University, discusses the latest recommendations from the National Comprehensive Cancer Network for treating patients with triple-negative breast cancer; data on early-stage and advanced disease; and the role of checkpoint inhibitors, antibody-drug conjugates, and PARP inhibitors.

Related Content